Opportunity Information: Apply for PAR 08 130
Apply for PAR 08 130
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "International Research in Infectious Diseases including AIDS (IRIDA) Program (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855 Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Jan 6, 2009 and posted on Jan 6, 2009.
- Applicants must submit their applications by Dec 16, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,400,000.00 to eligible and selected applicants.
- Eligible applicants include: Small businesses City or township governments Private institutions of higher education Special district governments State governments For profit organizations other than small businesses Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) County governments.
- Other Eligible Applicants include the following Eligible Agencies of the Federal Government Faith based or Community based Organizations Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The International Research in Infectious Diseases including AIDS (IRIDA) Program (R01) is a National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) funding opportunity designed to support investigator-initiated research on infectious diseases, including AIDS, that are important to an applicant's country. The central aim is to build and advance research projects led by organizations and institutions in eligible foreign countries, with a clear focus on locally relevant infectious disease priorities. While the program encourages collaboration between international research sites and U.S. investigators or institutions, those partnerships are optional rather than a requirement, meaning applicants can propose fully foreign-led projects as long as the research scope aligns with infectious diseases of interest to the country where the work will be based.
This opportunity uses the NIH Research Project Grant (R01) mechanism, which is NIH's standard award type for discrete, hypothesis-driven research projects with clearly defined objectives and methods. Under this announcement, applicants may request up to $100,000 per year in direct costs, for a project period of up to four years. In total, this caps direct costs at $400,000 over the full four-year period. NIAID indicated an intent to allocate approximately $800,000 per year for this program and anticipated making up to 10 new awards, although actual awards depend on the availability of appropriated funds and the quality and competitiveness of the applications received.
The program is categorized as a discretionary grant opportunity in the health funding area and is associated with CFDA numbers 93.855 (Allergy, Immunology and Transplantation Research) and 93.856 (Microbiology and Infectious Diseases Research). There is no cost sharing or matching requirement, which typically reduces administrative burden for applicants and makes the program more accessible for institutions that may not have flexible non-federal resources to contribute.
Eligibility is broad and includes a range of organization types, reflecting NIH's interest in supporting strong science wherever it can be conducted responsibly and effectively. Eligible applicants include non-U.S. entities (foreign organizations) and regional organizations, as well as U.S.-based organizations such as public and private institutions of higher education, small businesses, for-profit entities (other than small businesses), state and local governments (including city/township, county, special district, and state governments), and additional groups such as federal agencies and faith-based or community-based organizations where appropriate. Even with this wide eligibility list, the defining emphasis of the FOA is on applications from organizations/institutions in eligible foreign countries conducting research tied to infectious disease needs and interests of those countries.
Administrative details in the source record identify the announcement as Funding Opportunity Number PAR-08-130, titled "International Research in Infectious Diseases including AIDS (IRIDA) Program (R01)." It was posted on January 6, 2009, with an original and current closing date of December 16, 2010, and an archive date of January 16, 2011. The estimated total funding listed in the record is $2,400,000, which is consistent with a multi-year programmatic commitment rather than a guaranteed set-aside for every year. For full program requirements, applicants were directed to the NIH Grants Guide posting for the announcement, and technical access issues were routed to the NIH Office of Extramural Research (OER) webmaster contact.
FAQs: International Research in Infectious Diseases including AIDS (IRIDA) Program (R01) - PAR-08-130
What is the IRIDA Program (R01) grant opportunity?
The International Research in Infectious Diseases including AIDS (IRIDA) Program (R01) is a National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) funding opportunity that supports investigator-initiated research on infectious diseases, including AIDS, that are important to an applicant's country.
Which NIH Institute is offering this opportunity?
This opportunity is offered by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH).
What is the main goal of this program?
The central aim is to build and advance research projects led by organizations and institutions in eligible foreign countries, with a clear focus on locally relevant infectious disease priorities.
What types of research does this program support?
The program supports research on infectious diseases, including AIDS, especially when the proposed work addresses infectious disease needs and interests that are important to the applicant's country.
Does the research need to be locally relevant to the applicant's country?
Yes. The opportunity emphasizes research tied to infectious disease priorities that are important to the country where the applicant is based and where the research will be conducted.
Are partnerships with U.S. investigators or institutions required?
No. Collaboration between international research sites and U.S. investigators or institutions is encouraged, but it is optional rather than a requirement.
Can an application be fully foreign-led without a U.S. partner?
Yes. Applicants can propose fully foreign-led projects as long as the research scope aligns with infectious diseases of interest to the country where the work will be based.
What grant mechanism is used for this program?
This opportunity uses the NIH Research Project Grant (R01) mechanism, NIH's standard award type for discrete, hypothesis-driven research projects with clearly defined objectives and methods.
How much funding can be requested?
Applicants may request up to $100,000 per year in direct costs.
What is the maximum project period?
The project period may be up to four years.
What is the maximum total direct cost amount over the full project?
Because the cap is $100,000 per year in direct costs for up to four years, the total direct costs are capped at $400,000 over the full four-year period.
How much funding does NIAID intend to allocate each year for this program?
NIAID indicated an intent to allocate approximately $800,000 per year for the program, although actual amounts depend on appropriations and application quality.
How many awards were anticipated?
NIAID anticipated making up to 10 new awards, subject to the availability of appropriated funds and the competitiveness of submitted applications.
Is this funding guaranteed?
No. The number and size of awards depend on the availability of appropriated funds and the quality and competitiveness of applications received.
What is the total funding amount listed in the source record?
The estimated total funding listed in the record is $2,400,000, which is described as being consistent with a multi-year programmatic commitment rather than a guaranteed set-aside for every year.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad and includes non-U.S. entities (foreign organizations) and regional organizations, as well as U.S.-based organizations such as public and private institutions of higher education, small businesses, for-profit entities (other than small businesses), state and local governments (including city/township, county, special district, and state governments), and additional groups such as federal agencies and faith-based or community-based organizations where appropriate.
Is the program specifically focused on foreign organizations?
Yes. While many organization types are listed as eligible, the defining emphasis of the opportunity is on applications from organizations/institutions in eligible foreign countries conducting research tied to infectious disease needs and interests of those countries.
What funding category and area does this opportunity fall under?
The program is described as a discretionary grant opportunity in the health funding area.
What CFDA numbers are associated with this opportunity?
This opportunity is associated with CFDA numbers 93.855 (Allergy, Immunology and Transplantation Research) and 93.856 (Microbiology and Infectious Diseases Research).
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is PAR-08-130.
What is the official title of the announcement?
The title is "International Research in Infectious Diseases including AIDS (IRIDA) Program (R01)."
When was the opportunity posted?
The announcement was posted on January 6, 2009.
What were the closing date and archive date?
The original and current closing date was December 16, 2010, and the archive date was January 16, 2011.
Where were applicants directed for full program requirements?
Applicants were directed to the NIH Grants Guide posting for the announcement for full program requirements.
Where should technical access issues be directed?
Technical access issues were routed to the NIH Office of Extramural Research (OER) webmaster contact.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Landmarks of American History and Culture School Teachers
Previous opportunity: Improving Literacy Through School Libraries Competition Program CFDA 84.364A
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 08 130
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 08 130) also looked into and applied for these:
| Funding Opportunity |
|---|
| Electronic Health Record Implementation Initiative Apply for HRSA 09 198 Funding Number: HRSA 09 198 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| The Bernard Osher Foundation/NCCAM CAM Practitioner Research Career Development Award (K01) Apply for PAR 09 072 Funding Number: PAR 09 072 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers (P50) and Exploratory Grants for Centers (P20) for Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs) Apply for RFA HG 09 003 Funding Number: RFA HG 09 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Small Grant Program for Conference Support (R13) Apply for PA 06 074 Funding Number: PA 06 074 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $50,000 |
| NINDS Clinical Trial Planning Grant (R34) Apply for PAR 06 460 Funding Number: PAR 06 460 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Telehealth Network Grant Program Apply for HRSA 09 194 Funding Number: HRSA 09 194 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Collaborative R34s for Pilot Studies of Innovative Treatments in Mental Disorders (Collaborative R34) Apply for PA 09 075 Funding Number: PA 09 075 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Resources to Assist Investigations in Primary Immunodeficiency Diseases (U24) Apply for RFA AI 08 066 Funding Number: RFA AI 08 066 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nurse Faculty Loan Program Apply for HRSA 09 118 Funding Number: HRSA 09 118 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| CDC Grants for Public Health Research Dissertation (R36) Apply for PAR 07 231 Funding Number: PAR 07 231 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $35,000 |
| COOPERATIVE AGREEMENT WITH THE PAN AMERICAN HEALTH ORGANIZATION (PAHO) Protecting the Advances in Polio, Rubella and Measles Elimination Strengthening Immunization Programs in the Americas Apply for CDC PA IP09 901 Funding Number: CDC PA IP09 901 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Drug Free Communities Support Program Apply for SP 09 002 Funding Number: SP 09 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Service Area Competitions Additional Areas Apply for HRSA 09 214 Funding Number: HRSA 09 214 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Libby, Montana Amphibole Epidemiology Research Program (R01) Apply for RFA TS 09 001 Funding Number: RFA TS 09 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $965,000 |
| Disease Progression in Persons Exposed to Asbestos Contaminated Vermiculite Ore in Marysville, Ohio (R01) Apply for RFA TS 09 002 Funding Number: RFA TS 09 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Poison Center Support and Enhancement Grant Program Apply for HRSA 09 212 Funding Number: HRSA 09 212 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Part C CAPACITY DEVELOPMENT Apply for HRSA 09 129 Funding Number: HRSA 09 129 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Claude D. Pepper Older Americans Independence Centers (OAICs)(P30) Apply for RFA AG 10 003 Funding Number: RFA AG 10 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Structural Analyses of the Ligand Binding Properties of Taste and Smell Receptors (R21) Apply for PA 09 082 Funding Number: PA 09 082 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Program to Expand State Public Health Laboratory Capacity for Newborn Bloodspot Screening (U01) Apply for RFA EH 09 002 Funding Number: RFA EH 09 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 08 130", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.